Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Immunotherapy priming with neo-antigens

Here, Thomas Helleday, PhD, from the University of Sheffield, Sheffield, UK, discusses the use of neo-antigens to prime tumors for immunotherapy treatment. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.